Renal tubulointerstitial tissue damage, central pressure and vascular function in patients with untreated primary arterial hypertension

Nadcisnienie Tetnicze

Volumn 19, Issue 1, 2015, Pages 29-38

  Bednarski, Rafał ^a   Kubalski, Piotr ^b   Stefańska, Anna ^c   Odrowaz Sypniewska, Grazyna ^c   Manitius, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Euromedica Non Public Health Care Centre in Grudziadz   (Poland)

^c Dept of Pediatric Oncology and Hematology Nicolaus Copernicus   (Poland)

Author keywords

Arterial hypertension; CPP; NAG; Vessels

Indexed keywords

ADULT; AORTA PRESSURE; ARTERIAL PRESSURE; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; KIDNEY INJURY; KIDNEY INTERSTITIUM; MALE; MEAN ARTERIAL PRESSURE; MERCURY SPHYGMOMANOMETER; PULSE PRESSURE; RENAL TUBULOINTERSTITIAL TISSUE DAMAGE; SYSTOLIC BLOOD PRESSURE; TONOMETRY;

EID: 84926386912     PISSN: 14285851     EISSN: 16443101     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Temmar M., Jankowski P., Peltier M. et al. Intraaortic pulse pressure amplification in subjects at high coronary risk. Hypertension 2010; 55: 327-332.
2. Safar M.E., Blacher J., Protogerou A., Achimastos A. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. J. Hypertens. 2008; 26: 130-137.
3. Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2013; 34: 2159-2219.
4. McEniery C.M., Yasmin, McDonnell B. et al. Central pressure: variability and impact of cardiovascular risk factors: The Anglo-Cardiff Collaborative Trial II. Hypertension 2008; 51: 1476-1482.
5. Czekalski S., Oko A. Rola nerek w patogenezie pierwotnego nadcis̈nienia tętniczego. Czekalski S. Rutkowski B. (ed.) Nefropatia nadcis̈nieniowa. Termedia Wydawnictwo Medyczne, Poznań 2007: 40-48.
6. Johnson R.J., Herrera-Acosta J., Schreiner G.F., Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N. Engl. J. Med. 2002; 346: 913-923.
7. Deverux R.B., Koren M.J., De Simone G., Okin P.M., Kligfield P. Methods of detection of left ventricular hypertrophy: Application to hypertensive heart disease. Eur. Heart J. 1993; 14 (suppl. D): 8-15.
8. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate form serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999; 130: 461-470.
9. Safar M.E., Jankowski P. Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin. Sci. 2009; 116: 273-282.
10. Pędzich E., Szmigielski C., Gaciong Z. Central blood pressure as a risk marker for cardiovascular complications. Arterial Hypertension 2006; 10: 341-349.
11. Grobbee D.E., Bots M.L. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J. Int. Med. 1994; 236: 567-573.
12. Boutouyrie P., Bussy C., Lacolley P., Girere X., Laloux B., Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999; 100: 1387-1393.
13. Vlachopoulos C., Aznaouridis K., O'Rourke M. F., Safar M. E., Baou K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur. Heart J. 2010; 31: 1865-1871.
14. Szechiński J., Wiland P. N-acetyl-b-D-glucosaminidase urinary excretion as a parameter of renal proximal dysfunction in patients with renal failure. Pol. Arch. Med. Wewn. 1997, 98: 534-541.
15. Cowley A.W. Jr, Mattson D.L., Lu S., Roman R.J. The renal medulla and hypertension. Hypertension 1995; 25: 663-673.
16. Pontremoli R., Viazzi F., Martinolo C. et al. Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. Nephrol. Dial. Transplant. 1999; 14: 360-365.
17. Bigazzi R., Bianchi S., Nenci R., Baldari D., Baldari G., Compese V.M. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J. Hum. Hypertens. 1995; 9: 827-833.
18. Pedrinelli R., Dell'Omo G., Penno G. Dissociation between microalbuminuria and common carotid thickness in essential hypertensive men. J. Hum. Hypertens. 2000; 14: 831-835.
19. Takiuchi S., Kamide K., Miwa Y. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J. Hum. Hypertens. 2004; 18: 17-23.
20. Bednarski R., Donderski R., Manitius J. Role of vitamin D3 in arterial blood pressure control. Pol. Merk. Lek. 2007; 23: 136, 307-310.
21. Griffin M.D., Lutz W., Phan V.A. et al. Dendritic cell modulation by 1 alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor- dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2001; 98: 6800-6805.
22. Mathieu C., Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends. Mol. Med. 2002; 8: 174-179.